Ilika PLC - Romsey, England-based solid-state battery technology company - Expects its loss before interest, tax, depreciation and amortisation to widen. For its financial year ended April 30, the Ebitda loss is expected to widen to £7.0 million from £6.4 million a year before. Ilika forecasts annual revenue rising 60% to £800,000, from £500,000 a year ago. Trading has been in line with management expectations, the company said.
‘Ilika has 23 commercial orders from 20 customers, with miniature medical devices making up the majority of the demand. The applications cover 11 active implantable medical devices, three smart dental devices, two smart lenses, one for aerospace and three others,’ Ilika said.
Current stock price: 43.48 pence
12-month change: down 20%
Copyright 2023 Alliance News Ltd. All Rights Reserved.
